This trial will compare the clinical outcomes and economic viability of using patient-specific instrumentation for total knee arthroplasty in obese patients.
1 Primary · 3 Secondary · Reporting Duration: 1 year, 5 years and 10 years post-operatively
Active Control
Experimental Treatment
194 Total Participants · 2 Treatment Groups
Primary Treatment: Attune TruMatch (TM) Patient-Specific Instrumentation · No Placebo Group · N/A
Age 20 - 70 · All Participants · 4 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: